DALLAS, July 6, 2015 /PRNewswire/ --
According to a new market research report "Contrast Media/Contrast Agents Market By Product (Iodinated, Gadolinium and Barium), By Technique (X-ray, CT, MRI, Cath Lab and Ultrasound) and By Application (Radiology, Interventional Radiology and Interventional Cardiology) - Global Trends and Forecast to 2020", published by MarketsandMarkets, the Contrast Media/Contrast Agents Market is expected to reach around $5.17 Billion by 2020, at a CAGR of 4.2% during the forecast period (2015 to 2020).
Browse 72 market data Tables and 38 Figures spread through 191 Pages and in-depth TOC on "Contrast Media/Contrast Agents Market"
Early buyers will receive 10% customization on this report.
This report studies the global contrast media/contrast agents market for the forecast period of 2015 to 2020. This market is expected to reach a value of $5.17 billion by 2020, from an estimated value of $4.21 billion in 2015, at a CAGR of 4.2% during the period under consideration.
Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=911
The global contrast media/contrast agents market has been segmented on the basis of product, route of administration, indication, procedure, application, and region.
Based on product, the contrast media/contrast agents market is categorized into barium, iodinated, gadolinium, and microbubble contrast media. In 2015, the iodinated contrast media segment is estimated to account for the largest share of the contrast media/contrast agents market, among products. However, the microbubble contrast media segment is expected to grow at the highest CAGR during the given forecast period.
On the basis of route of administration, the overall market has been segmented into oral, injectable, rectal, and urethral routes. In 2015, the injectable segment is expected to account for the largest share of the contrast media/contrast agents market, among the different routes of administration.
Based on indication, the market is segmented into cardiovascular disorders, oncology, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, and nephrological disorders. In 2015, the cardiovascular disorders segment is estimated to account for the largest share of the global contrast media/contrast agents market, by indication.
On the basis of procedure, the global contrast media market is segmented into X-ray/CT, MRI, and ultrasound. In 2015, the X-ray/CT segment is expected to account for the largest share of the contrast media/contrast agents market, among the procedures. However, the ultrasound segment is expected to register the highest CAGR during the given forecast period.
Furthermore, based on application, the global market has been segmented into radiology, interventional radiology, and interventional cardiology. In 2015, the radiology segment is estimated to account for the largest share of the contrast media/contrast agents market, among the applications.
North America, Europe, Asia-Pacific, and Rest of the World (RoW) are the key regions considered for a geographic analysis of the global contrast media market. In 2015, North America is estimated to account for the largest share of the given market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is expected to grow at the highest CAGR during the given forecast period, and also serve as a revenue pocket for companies offering contrast media/contrast agents in the near future.
Some of the major players in the global contrast media/contrast agents market include Bayer Healthcare (Germany), GE Healthcare (U.K.), Guerbet Group (France), Bracco Imaging S.p.A. (Italy), Mallinckrodt PLC (Ireland), and Lantheus Medical Imaging (U.S.), among others.
Browse Related Reports:
Diagnostic Imaging Equipment Market by Modality [Digital X-ray Imaging, Ultrasound (Color Doppler, Portable), Magnetic Resonance Imaging, CT scanner (Low-, mid-, & High-end), Mammography, PET, SPECT] - Emerging Markets (BRIC - Brazil, Russia, India, and China) - 2011-2018
Diagnostic Imaging Market by X-ray Systems (Digital, Analog, Portable), Computed Tomography, Ultrasound Imaging Systems (2D, 3D, 4D, Doppler), MRI Machines (Closed & Open), and Nuclear Imaging Systems (SPECT, PET, PET/CT) - Global Forecasts to 2018
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets